Patent Assignment
Reel/Frame 073058/0985
Corrective Assignment to Correct the Removal of 8 Property Numbers Previously Recorded at Reel: 072341 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Recorded: 2025-10-08
Pages: 5
Assignor
CELATOR PHARMACEUTICALS, INC.
Executed: 2025-06-24
Assignee
JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
3000 EL CAMINO REAL, 2 PALO ALTO SQUARE, SUITE 600, PALO ALTO, CALIFORNIA, 94306
Covered Properties
(32)
Lipid Carrier Compositions with Enhanced Blood Stability
Compositions for Delivery of Drug Combinations
Compositions for Delivery of Drug Combinations
Fixed Ratio Drug Combination Treatments for Solid Tumors
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Liposome Loading with Metal Ions
Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
Particulate Constructs for Release of Active Agents
Method of Lyophilizing Liposomes
Compositions for Delivery of Drug Combinations
Remote Loading of Sparingly Water-Soluble Drugs into Liposomes
Remote Loading of Sparingly Water-Soluble Drugs into Lipid Vesicles
Improved Nanoparticle Delivery Systems
Assays and Methods for Selecting a Treatment Regimen for a Subject with Leukemia
Method of Lyophilizing Liposomes
Remote Loading of Sparingly Water-Soluble Drugs into Liposomes
Method of Lyophilizing Liposomes
Remote Loading of Sparingly Water-Soluble Drugs into Liposomes
Remote Loading of Sparingly Water-Soluble Drugs into Lipid Vesicles
Nanoparticle Delivery Systems
Assays and Methods for Selecting a Treatment Regimen for a Subject with Leukemia
Low-Intensity Treatment of Hematological Disorders
Treatment of Hematological Disorders
Method of Lyophilizing Liposomes
Application:
17/812,414 →
Publication:
US US20230172855A1
Liposomal Formulations of Bcl Inhibitors
Remote Loading of Sparingly Water-Soluble Drugs Into Lipid Vesicles
Assays and Methods for Selecting a Treatment Regimen for a Subject with Leukemia
Application:
18/316,719 →
Publication:
US US20230279503A1
Methods for Preparing Liposomal Formulations
Application:
18/579,824 →
Publication:
US US20240350411A1
Treatment of Hematological Disorders
Remote Loading of Sparingly Water-Soluble Drugs into Lipid Vesicles
Application:
18/792,017 →
Publication:
US US20240424007A1
Low-Intensity Treatment of Hematological Disorders
Application:
19/247,599 →
Publication:
US US20260014183A1
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jun 15, 2012
From: THOMAS, MCNERNEY & PARTNERS II, L.P.; TMP NOMINEE II, LLC; TMP ASSOCIATES II, L.P.; DOMAIN PARTNERS VI, L.P.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 028385/0371 →
Assignment of Assignor's Interest
Jul 23, 2013
From: MAYER, LAWRENCE D.; ALLEN, CHRISTINE J.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 030858/0007 →
Assignment of Assignor's Interest
Jul 23, 2013
From: PRUD'HOMME, ROBERT K.; SAAD, WALID S.
To: THE TRUSTEES OF PRINCETON UNIVERSITY
Reel/Frame 030858/0115 →
Assignment of Assignor's Interest
Jun 2, 2014
From: CABRAL-LILLY, DONNA; MAYER, LAWRENCE; TARDI, PAUL; WATKINS, DAVID
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 033011/0685 →
Security Agreement
Jul 12, 2016
From: CELATOR PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 039312/0397 →
Assignment of Assignor's Interest
Jul 21, 2016
From: HAYES, MARK E.; NOBLE, CHARLES O.; SZOKA, FRANCIS C., JR.
To: ZONEONE PHARMA, INC.
Reel/Frame 039215/0414 →
Assignment of Assignor's Interest
Aug 3, 2016
From: TARDI, PAUL; HARASYM, TROY; WEBB, MURRAY; SHEW (DECEASED), CLIFFORD
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 039335/0418 →
Assignment of Assignor's Interest
Aug 3, 2016
From: MAYER, LAWRENCE; BALLY, MARCEL
To: BCCA BRANCH
Reel/Frame 039335/0404 →
Assignment of Assignor's Interest
Aug 3, 2016
From: BCCA BRANCH
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 039335/0411 →
Assignment of Assignor's Interest
Mar 7, 2018
From: CABRAL-LILLY, DONNA; MAYER, LAWRENCE; TARDI, PAUL; WATKINS, DAVID
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 045133/0667 →
Assignment of Assignor's Interest
Apr 25, 2018
From: HAYES, MARK E.; NOBLE, CHARLES O.; SZOKA, FRANCIS C., JR.
To: ZONEONE PHARMA, INC.
Reel/Frame 045637/0293 →
Assignment of Assignor's Interest
Jan 3, 2019
From: HAYES, MARK E.; NOBLE, CHARLES O.; SZOKA, FRANCIS C., JR.
To: ZONEONE PHARMA, INC.
Reel/Frame 047896/0179 →
Assignment of Assignor's Interest
Mar 11, 2019
From: WAN, LEON; TARDI, PAUL; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 048565/0645 →
Assignment of Assignor's Interest
Mar 11, 2019
From: LUI, WINNIE
To: CELATOR PHARMACEUTICALS INC.
Reel/Frame 048565/0648 →
Security Agreement
May 5, 2021
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 056151/0010 →
Release of Security Interest
May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Assignment of Assignor's Interest
Dec 2, 2022
From: TARDI, PAUL; MAYER, LAWRENCE
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 061962/0590 →
Assignment of Assignor's Interest
Dec 2, 2022
From: GORDON, MAX; TYNER, JEFFREY
To: OREGON HEALTH & SCIENCE UNIVERSITY
Reel/Frame 061962/0579 →
Assignment of Assignor's Interest
Jan 18, 2023
From: ZONEONE PHARMA, INC.
To: CELATOR PHARMACEUTICALS, INC.
Reel/Frame 062415/0485 →
Security Agreement
Jul 26, 2024
From: CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; GW PHARMA LIMITED; JAZZ PHARMACEUTICALS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 068173/0155 →
Change of Name
Aug 7, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 072341/0137 →
Corrective Assignment to Correct the Remove 2 Application Numbers Previously Recorded at Reel: 07234 Frame: 0137. Assignor(S) Hereby Confirms the Change of Name.
Oct 9, 2025
From: CELATOR PHARMACEUTICALS, INC.
To: JAZZ PHARMACEUTICALS THERAPEUTICS, INC.
Reel/Frame 073133/0142 →